What factors do you use when selecting which NGS platform to use for sequencing solid tumors?

For instance, do you factor availability of RNAseq, inclusion of normal blood controls, and QNS rates into your decision?

Answer from: Medical Oncologist at Academic Institution

QNS rates are roughly comparable between vendors such as Caris, Tempus, FoundationOne. The presence of normal blood controls can help, but is not a criterion for complete exclusion of a platform for me. Many institutions have established workflow to send tests to a certain company for certain diseas...

Comments

Medical Oncologist at Community Hospital
Great thoughts and answer. I would also challenge ...

Please select the option that best describes you:

What factors do you use when selecting which NGS platform to use for sequencing solid tumors?

Related Questions